drugset / Trial / NCT05460455
A Study to Evaluate Multi-dose of HB0034 in Healthy Adult Participants
RandomizedParallel-groupDouble-blindOther
Summary
The aim of this study is to investigate the safety and tolerability of HB0034 in healthy subjects following multiple-dose.
Timeline
- Start
- 2022-10-13
- Primary completion
- 2023-06-09
- Completion
- 2023-12-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | HB0034 | Monoclonal antibody | — | — |
Indications
No indication recorded.